Merck KGaA share price up after 1st-qtr results

19 May 2016
merckkgaa-big

German life sciences and pharma company Merck KGaA (MRK: DE) has increased its first-quarter 2016 ales and earnings following the acquisition of US-based pharma equipment maker Sigma-Aldrich.

Shares in the company had risen by 3.4% to 85.47 euros in mid-afternoon trading on Thursday.

It was not just November 2015’s purchase of Sigma-Aldrich, which increased group net sales by 20.5% compared to 1st-qtr 2015, as they went up from $3.36 billion to $4.15 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical